SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-003170
Filing Date
2020-02-20
Accepted
2020-02-20 16:32:50
Documents
5
Period of Report
2020-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200219_8k.htm 8-K 32360
2 EXHIBIT 1.1 ex_173384.htm EX-1.1 58978
3 EXHIBIT 5.1 ex_173498.htm EX-5.1 19667
4 EXHIBIT 10.1 ex_173381.htm EX-10.1 214074
5 smlogo.jpg GRAPHIC 3991
  Complete submission text file 0001437749-20-003170.txt   331828
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20635642
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences